Skip to main content Accessibility help
×
Home

Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis

Published online by Cambridge University Press:  02 January 2015


Cassandra D. Salgado
Affiliation:
Brody School of Medicine, East Carolina University, Greenville, North Carolina
Barry M. Farr
Affiliation:
Department of Medicine, University of Virginia Health System, Charlottesville, Virginia

Abstract

Background:

Because patients with vancomycin-resistant Enterococcus bacteremia (VREB) usually have a higher severity of illness, it has been unclear whether VREB is worse than vancomycin-susceptible Enterococcus bacteremia (VSEB).

Methods:

Data on morbidity and case fatality rates and costs were pooled from studies comparing VREB and VSEB, identified by Medline (January 1986 to April 2002) and meeting abstracts. Heterogeneity across studies was assessed with contingency table chi-square. Multivariate analyses (MVAs) controlling for other predictors were evaluated.

Results:

Thirteen studies compared case-fatality rates of VREB and VSEB. VREB case fatality was significantly higher (48.9% vs 19%; RR, 2.57; CI95, 2.27 to 2.91; attributable mortality = 30%). Five studies compared VREB with VSEB when bacteremia was the direct cause of death; VREB case fatality was significantly higher (39.1% vs 21.8%; RR, 1.79; CI95, 1.28 to 2.5; attributable mortality = 17%). Four MVAs found significant increases in case-fatality rates (OR 2.10 to 4.0), 3 showed trends toward increase (OR, 1.74 to 3.34 with wide confidence intervals), and 3 with low statistical power found no difference. VREB recurred in 16.9% versus 3.7% with VSEB (P < .0001). Three studies reported significant increases in LOS, costs, or both with VREB.

Conclusion:

Most studies have had inadequate sample size, inadequate adjustment for other predictors of adverse outcomes, or both, but available data suggest that VREB is associated with higher recurrence, mortality, and excess costs than VSEB including multiple studies adjusting for severity of illness.


Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2003

Access options

Get access to the full version of this content by using one of the access options below.

References

1.Leclercq, R, Derlot, E, Duval, J, Courvalin, P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157161.CrossRefGoogle ScholarPubMed
2.Uttley, AH, Collins, CH, Naidoo, J, George, R. Vancomycin-resistant enterococci. Lancet 1988;1:5758.CrossRefGoogle ScholarPubMed
3.Byers, KE, Anglim, AM, Anneski, CJ, et al.A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22:140147.CrossRefGoogle ScholarPubMed
4.Ostrowsky, BE, Trick, WE, Sohn, AH, et al.Control of vancomycin-resistant Enterococcus in healthcare facilities in a region. N Engl J Med 2001;344:14271433.CrossRefGoogle Scholar
5.National Nosocomial Infection Surveillance (NNIS) System. NNIS system report, data from January 1990-1999, issued June 1999. Am J Infect Control 1999;27:520532.CrossRefGoogle Scholar
6.Gonzales, RD, Schreckenberger, PC, Graham, MB, Kelkar, S, DenBesten, K, Quinn, JP. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 2001;357:1179.CrossRefGoogle Scholar
7.Stosor, V, Peterson, LR, Postelnick, M, Noskin, GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998;158:522527.CrossRefGoogle Scholar
8.Linden, PK, Pasculle, AW, Manez, R, et al.Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996;22:663670.CrossRefGoogle ScholarPubMed
9.Bhavnani, SM, Drake, JAForrest, A, et al.A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000;36:145158.CrossRefGoogle Scholar
10.Song, X, Perl, T. Vancomycin-resistant enterococcal (VRE) nosocomial bloodstream infections (BSD: the attributable mortality, length of stay, and excess cost. Presented at the 37th Annual Meeting of the Infectious Diseases Society of America; November 18-21, 1999; Philadelphia, PA.Google Scholar
11.Lautenbach, E, Bilker, WB, Brennan, PJ. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 1999;20:318323.CrossRefGoogle ScholarPubMed
12.Shay, DK, Maloney, SA, Montecalvo, M, et al.Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:9931000.CrossRefGoogle ScholarPubMed
13.Stroud, L, Edwards, J, Danzing, L, Culver, D, Gaynes, R. Risk factors for mortality associated with enterococcal bloodstream infections. Infect Control Hosp Epidemiol 1996;17:576580.CrossRefGoogle ScholarPubMed
14.Ostrowsky, B, Steinberg, JT, Farr, B, Sohn, AH, Sinkowitz-Cochran, RL, Jarvis, WR. Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients? Infect Control Hosp Epidemiol 2001;22:116119.CrossRefGoogle ScholarPubMed
15.Bhorade, SM, Christenson, J, Pohlman, AS, Arnow, PM, Hall, JB. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest 1999;115:10851091.CrossRefGoogle ScholarPubMed
16.Webb, M, Riley, LW, Roberts, RB. Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization. Clin Infect Dis 2001;33:445452.CrossRefGoogle Scholar
17.Edmond, MB, Ober, JF, Dawson, JD, Weinbaum, DL, Wenzel, RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:12341239.CrossRefGoogle Scholar
18.Papanicolaou, GA, Meyers, BR, Meyers, J, et al.Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996;23:760766.CrossRefGoogle ScholarPubMed
19.Morris, JG Jr, Shay, DK, Hebden, JN, et al.Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250259.CrossRefGoogle Scholar
20.Garbutt, JM, Ventrapragada, M, Littenberg, B, Mundy, LM. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 2000;30:466472.CrossRefGoogle Scholar
21.Boyle, JF, Soumakis, SA, Rendo, A, et al.Epidemiologic analysis and genotypie characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:12801285.Google Scholar
22.Lucas, GM, Lechtzin, N, Puryear, DW, Yau, LL, Flexner, CW, Moore, RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 1998;26:11271133.CrossRefGoogle ScholarPubMed
23.Peset, V, Talion, P, Sola, C, et al.Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. Eur J Clin Microbiol Infect Dis 2000;19:742749.CrossRefGoogle ScholarPubMed
24.Gleason, T, Crabtree, T, Pelletier, S, et al.Prediction of poorer prognosis by infection with antibiotic-resistant gram-positive cocci than by infection with antibiotic sensitive strains. Arch Surg 1999:134:10331040.CrossRefGoogle ScholarPubMed
25.Montecalvo, MA, Shay, DK, Patel, P, et al.Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996;56:14581462.CrossRefGoogle Scholar
26.Lodise, TP, McKinnon, PS, Tam, VH, Rybak, MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant Enterococcus in a level 1 trauma center. Clin Infect Dis 2002;34:922929.CrossRefGoogle Scholar
27.Vergis, E, Hayden, M, Chow, J, et al.Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. Ann Intern Med 2001;135:484492.CrossRefGoogle ScholarPubMed
28.Quale, J, Landman, D, Atwood, E, et al.Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control 1996;24:372379.CrossRefGoogle ScholarPubMed
29.Livornese, LL Jr, Dias, S, Samel, C, et al.Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112116.CrossRefGoogle ScholarPubMed
30.Lee, HK, Lee, WG, Cho, SR. Clinical and molecular biological analysis of a nosocomial outbreak of vancomycin-resistant enterococci in a neonatal intensive care unit. Acta Paediatr 1999;88:651654.CrossRefGoogle Scholar
31.Newell, KAMillis, JM, Arnow, PM, et al.Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998;65:439442.CrossRefGoogle ScholarPubMed
32.Tornieporth, NG, Roberts, RB, John, J, Hafner, A, Riley, LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996;23:767772.CrossRefGoogle ScholarPubMed
33.D'Agata, EM, Li, H, Gouldin, C, Tang, YW. Clinical and molecular characterization of vancomycin-resistant Enterococcus faecium strains during establishment of endemicity. Clin Infect Dis 2001;33:511516.CrossRefGoogle ScholarPubMed
34.Still, J, Law, E, Friedman, B, Fuhrman, S, Newton, T. Vancomycin-resistant organisms on a burn unit. South Med J 2001;94:810812.CrossRefGoogle ScholarPubMed
35.Wells, C, Juni, B, Cameron, S, et al.Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical or surgical patients. Clin Infect Dis 1995;21:4550.CrossRefGoogle ScholarPubMed
36.Gray, J, George, R. Experience of vancomycin-resistant enterococci in a children's hospital. J Hosp Infect 2000;45:1118.CrossRefGoogle Scholar
37.Lam, S, Singer, C, Tucci, V, Morthland, VH, Kaller, MA, Isenberg, HD. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control 1995;23:170180.CrossRefGoogle ScholarPubMed
38.Krcmery, V, Bilikova, E, Svetlansky, I, Kovacicova, G. Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia? Clin Infect Dis 2001;32:11101112.CrossRefGoogle ScholarPubMed
39.Lai, KK, Kelley, AL, Melvin, ZS, Belliveau, PP, Fontecchio, SA. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Infect Control Hosp Epidemiol 1998;19:647652.CrossRefGoogle Scholar
40.Edmond, MB, Ober, JF, Weinbaum, DL, et al.Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:11261133.CrossRefGoogle ScholarPubMed
41.Kapur, D, Dorsky, D, Feingold, JM, et al.Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2000;25:147152.CrossRefGoogle ScholarPubMed
42.Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993. MMWR 1993;42:597598.Google Scholar
43.Mainous, MR, Lipsett, PA, O'Brien, M, Johns Hopkins SICU Study Group. Enterococcal bacteremia in the surgical intensive care unit: does vancomycin resistance affect mortality? Arch Surg 1997;132:7681.CrossRefGoogle ScholarPubMed
44.Jernigan, J, Hadziyannis, E, Schwarzmann, S, Nolte, F. Vancomycin-resistant Enterococcus faecium (VRE) bacteremia in severely neutropenic patients. Presented at the 36th Annual Meeting of the Infectious Diseases Society of America; September 18-20, 1996; New Orleans, LA.Google Scholar
45.Harrell, FE Jr, Lee, KL, Mark, DB. Multivariable prognostic model: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361387.3.0.CO;2-4>CrossRefGoogle Scholar

Altmetric attention score


Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 0
Total number of PDF views: 16 *
View data table for this chart

* Views captured on Cambridge Core between September 2016 - 5th December 2020. This data will be updated every 24 hours.

Hostname: page-component-b4dcdd7-tf8mx Total loading time: 1.158 Render date: 2020-12-05T02:11:08.015Z Query parameters: { "hasAccess": "0", "openAccess": "0", "isLogged": "0", "lang": "en" } Feature Flags last update: Sat Dec 05 2020 01:59:35 GMT+0000 (Coordinated Universal Time) Feature Flags: { "metrics": true, "metricsAbstractViews": false, "peerReview": true, "crossMark": true, "comments": true, "relatedCommentaries": true, "subject": true, "clr": false, "languageSwitch": true }

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *